Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 15M | 14M | 17M | 21M | 26M | 23M |
| Cost of revenue | 15M | 13M | 12M | 13M | 17M | 15M |
| Research and development | 15M | 12M | 12M | 13M | 12M | 13M |
| Selling, general and administrative | 18M | 13M | 14M | 12M | 11M | 12M |
| Operating expenses | 48M | 38M | 39M | 38M | 40M | 39M |
| Operating income | −32M | −23M | −22M | −18M | −14M | −17M |
| Interest expense | 47,000 | 64,000 | 48,000 | 28,000 | 7,000 | 9,000 |
| Pre-tax income | −30M | −22M | −20M | −16M | −39M | −13M |
| Income tax | 16,000 | 3,000 | 2,000 | 7,000 | 3,000 | 4,000 |
| Net income | −30M | −22M | −20M | −16M | −39M | −13M |
| Earnings per share | −0.29 | −0.24 | −0.23 | −0.18 | −0.64 | −0.24 |
| Earnings per share, diluted | −0.29 | −0.24 | −0.23 | −0.18 | −0.64 | −0.24 |
| Weighted average shares | 104M | 89M | 89M | 87M | 61M | 52M |
| Weighted average shares, diluted | 104M | 89M | 89M | 87M | 61M | 52M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 74M | 124M | 50M | 53M | 71M | 91M | 76M | 48M |
| Short-term investments | 160M | 116M | 101M |
| Metric | 31/03/2026 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|
| Operating cash flow | −22M | — | −18M | — | — |
| Depreciation and amortisation | 2M | 3M | 3M | 3M | 3M |
| Share-based compensation |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 120M |
| 115M |
| 94M |
| 68M |
| 39M |
| Receivables | 13M | 16M | 14M | 10M | 11M | 8M | 13M | 13M |
| Current assets | 258M | 268M | 174M | 193M | 206M | 203M | 170M | 113M |
| Property, plant and equipment | 48M | 45M | 47M | 46M | 48M | 48M | 50M | 53M |
| Total assets | 325M | 334M | 243M | 259M | 273M | 270M | 240M | 186M |
| Current liabilities | 39M | 40M | 36M | 32M | 30M | 31M | 36M | 34M |
| Total liabilities | 71M | 73M | 71M | 68M | 66M | 67M | 73M | 73M |
| Equity | 255M | 261M | 171M | 191M | 207M | 203M | 167M | 112M |
| Shares outstanding | 105M | 102M | 89M | 89M | 88M | 85M | 71M | 53M |
| Shares issued | 105M | 102M | 89M | 89M | 88M | 85M | 71M | 53M |
| 3M |
| — |
| 2M |
| — |
| — |
| Capital expenditure | 3M | — | 3M | — | — |
| Investing cash flow | −46M | — | −23M | — | — |
| Financing cash flow | 18M | — | 20M | — | — |